Source: Yunnan Fuwai Cardiovascular Hospital · Published: 22 April 2026 Original URL: https://www.yntv.cn/news/20260422/1776843225794758.html In April 2026, an intercontinental cardiac interventional procedure spanning ten thousand kilometres was successfully completed. Professor Pan Xiangbin, Executive President of Yunnan Fuwai Cardiovascular Hospital, was in Bordeaux, France. Using China's original pure-ultrasound-guided interventional technology system and a domestically developed surgical robot system, he successfully performed a fully ultrasound-guided, robot-assisted transcatheter mitral edge-to-edge repair on a patient ten thousand li away. Professor Pan Xiangbin, together with leading international cardiovascular experts in France, performing ultrasound-guided interventional mitral edge-to-edge repair via an intercontinental remote robot Years in the Making: A Technological Leap from Two Thousand Kilometres to a Transcontinental Ten Thousand Li This transcon...

Source: Chinese Academy of Medical Sciences & Peking Union Medical College — Institutional News (report from Fuwai Hospital) Original URL: https://www.pumc.edu.cn/pub/cams/yxbd/422b6552aeb54ef0ac5ee1e96c5336ef.htm Fuwai Hospital of the Chinese Academy of Medical Sciences, in collaboration with the Chinese Academy of Sciences, has released a magnetofluid-based intracardiac 3D printing technology, published in the top international journal Nature. Introduction: A Paradigm Revolution from "Metal Devices" to "Fluid Shaping" Background As population ageing intensifies, atrial fibrillation has become a highly prevalent cardiovascular disease worldwide, with a global patient total of 60 million. The most lethal complication of atrial fibrillation is stroke (cerebral embolism). Clinical research has confirmed that about 90% of left atrial thrombi in patients with atrial fibrillation originate in the left atrial appendage. When atrial fibrillation occurs, blood readily forms...

Headline:Two Papers in One Day: Shasha HanTeam at the School of Population Medicine and Public Health Publishes Health AI Research inNature MedicineandNature Health January 19, 2026 — Uneven healthcare resources and persistent workforce shortages in primary care have made one question increasingly urgent: How can artificial intelligence (AI) be designed and deployed in real-world settings, especially in resource-limited rural areas? On January 19, 2026, the team led by Shasha Han at the School of Population Medicine and Public Health (SPMPH) made important progress. Two studies appeared the same day in Nature Medicine and Nature Health.One introduced a codesign methodology and a large language model (LLM) chatbot built through that approach for primary care; the other focused on the transition from primary to specialist care. The studies moved beyond technical performance metrics. They were grounded in real primary care and hospital settings across China, including rural a...

On March 5, 2026, Associate Research Fellow Wang Ye of the School of Population Medicine and Public Health (SPMPH) at Peking Union Medical College, together with Professor Jennifer K. Quint's team at Imperial College London, published a research paper online in the European Respiratory Journal (ERJ) titled “Developing and Validating the CE-MACE Model to Predict One-Year Major Adverse Cardiovascular Events Post COPD Exacerbation Using Routine Healthcare Data.” Using routine healthcare data, the study developed and validated the CE-MACE prediction model, which accurately identifies the risk of major adverse cardiovascular events (MACE) within one year following an acute exacerbation of chronic obstructive pulmonary disease (COPD), providing a scientific tool to support multidisciplinary, integrated care for COPD patients. Framework for the development and validation of the CE-MACE model Patients with chronic obstructive pulmonary disease (COPD) face a higher risk of card...

Liver injury is a major complication of severe dengue, yet its pathological evolution and key molecular features remain to be systematically elucidated. On July 16, 2026, a research team led by Professor Wei Wang from the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, in collaboration with Professor Juntao Yang from the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, published a paper in Journal of Hepatology (IF = 40.1) entitled "Disruption of carbon metabolism by the hepatic mononuclear phagocytic system drives liver injury in a mouse model of severe dengue". By integrating multi-omics and single-cell RNA sequencing, the study systematically mapped the dynamic hepatic molecular landscape in a mouse model of severe dengue, and demonstrated that fostamatinib, an already marketed drug, significantly alleviates liver injury, offering a new strategy and direction for clinical intervention in severe dengue. Dengue fever i...

The FZOCUS‑1 study, led by Professor Lingying Wu and co‑corresponding author Professor Ning Li of the Cancer Hospital of the Chinese Academy of Medical Sciences, was published in January in CA: A Cancer Journal for Clinicians. It is the journal's first clinical research articleof gynecologic oncology. Ovarian cancer is the most lethal malignancies and carries the worst prognosis among gynecologic malignancies. Approximately 70% of patients are diagnosed at advanced stages, with a 5‑year survival rate of 30‑40%. With the approval of poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors and anti-angiogenic drugs for first-line maintenance therapy for advanced ovarian cancer, the survival has been significantly improved. However, which patients should receive monotherapy or combination therapy based on different biomarker status is unclear. For example, the options of maintenance treatment for patients with breast cancer susceptibility gene (BRCA) mutations include P...